Remote Diagnostic Technologies Ltd. (RDT), an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham.
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CLEVELAND (WJW) – It’s bigger than a Fitbit ...
Tempus AI delivered strong Q1 results, driven by the Ambry Genetics acquisition and a major AstraZeneca contract, boosting revenue and backlog. The AI precision medicine company grew core revenues 32% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results